HLN ConsultingInnovators in Health Informatics

Lux Phatak

New Version of HLN’s Award Winning Open Source Immunization Forecaster Released and Working on COVID-19 Vaccine Support

Share

New Version of HLN’s Award Winning Open Source Immunization Forecaster Released and Working on COVID-19 Vaccine Support

On November 6, 2020, HLN released a new version (v1.24.2) of the Immunization Calculation Engine (ICE). ICE is a state-of-the-art open source software system that provides clinical ...

On November 6, 2020, HLN released a new version (v1.24.2) of the Immunization Calculation Engine (ICE). ICE is a state-of-the-art open source software system that provides clinical decision support for immunizations for use in Immunization Information Systems (IIS), Electronic Health Record (EHR), and Personal Health Record (PHR) Systems.

HLN Participates in NACCHO360 Virtual Conference

Share

HLN Participates in NACCHO360 Virtual Conference

Dr. Noam Arzt, President of HLN, recorded a session for the NACCHO360 Virtual Conference available during the week of July 6 for registered attendees in the Information and Technol ...

Dr. Noam Arzt, President of HLN, recorded a session for the NACCHO360 Virtual Conference available during the week of July 6 for registered attendees in the Information and Technology track. Titled, “Interoperability Update for Public Health: What’s In Store for the Coming Decade,” this talk reviews major developments in healthcare interoperability that will affect public health over the coming years.

Leveraging the ICE Open Source Immunization Forecaster during COVID-19

Share

Leveraging the ICE Open Source Immunization Forecaster during COVID-19

Like many things in the age of COVID-19, the vaccine development landscape is unlike anything we have seen in our lifetimes. There are over 100 SARS-CoV-2 vaccines currently in dev ...

Like many things in the age of COVID-19, the vaccine development landscape is unlike anything we have seen in our lifetimes. There are over 100 SARS-CoV-2 vaccines currently in development, many of which are utilizing new technologies not used in any currently licensed vaccine. The potential impact on immunization schedules (clinical guidelines for clinicians) and immunization clinical decision support is significant.